PDB Short entry for 2RSY HEADER TRANSFERASE/SIGNALING PROTEIN 10-SEP-12 2RSY TITLE SOLUTION STRUCTURE OF THE SH2 DOMAIN OF CSK IN COMPLEX WITH A TITLE 2 PHOSPHOPEPTIDE FROM CBP COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE CSK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SRC HOMOLOGY 2 DOMAIN, UNP RESIDUES 80-173; COMPND 5 SYNONYM: C-SRC KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: PHOSPHOPROTEIN ASSOCIATED WITH GLYCOSPHINGOLIPID-ENRICHED COMPND 10 MICRODOMAINS 1; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: CBP, UNP RESIDUES 288-321; COMPND 13 SYNONYM: CSK-BINDING PROTEIN, TRANSMEMBRANE PHOSPHOPROTEIN CBP; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: CSK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ORIGAMI B (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PGEX-6P-1; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 13 ORGANISM_COMMON: RAT; SOURCE 14 ORGANISM_TAXID: 10116; SOURCE 15 GENE: PAG1, CBP, PAG; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 20 EXPRESSION_SYSTEM_VECTOR: PGEX-6P-1 KEYWDS SH2 DOMAIN, CSK, CBP, SOLUTION STRUCTURE, TRANSFERASE-SIGNALING KEYWDS 2 PROTEIN COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR H.TANAKA,K.AKAGI,C.ONEYAMA,M.TANAKA,Y.SASAKI,T.KANOU,Y.LEE, AUTHOR 2 D.YOKOGAWA,M.DEBENECKER,A.NAKAGAWA,M.OKADA,T.IKEGAMI REVDAT 2 25-DEC-19 2RSY 1 JRNL REMARK SEQADV LINK REVDAT 1 10-APR-13 2RSY 0 JRNL AUTH H.TANAKA,K.AKAGI,C.ONEYAMA,M.TANAKA,Y.SASAKI,T.KANOU, JRNL AUTH 2 Y.H.LEE,D.YOKOGAWA,M.W.DOBENECKER,A.NAKAGAWA,M.OKADA, JRNL AUTH 3 T.IKEGAMI JRNL TITL IDENTIFICATION OF A NEW INTERACTION MODE BETWEEN THE SRC JRNL TITL 2 HOMOLOGY 2 DOMAIN OF C-TERMINAL SRC KINASE (CSK) AND JRNL TITL 3 CSK-BINDING PROTEIN/PHOSPHOPROTEIN ASSOCIATED WITH JRNL TITL 4 GLYCOSPHINGOLIPID MICRODOMAINS. JRNL REF J.BIOL.CHEM. V. 288 15240 2013 JRNL REFN ESSN 1083-351X JRNL PMID 23548896 JRNL DOI 10.1074/JBC.M112.439075 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR, CYANA REMARK 3 AUTHORS : BRUKER BIOSPIN (XWINNMR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RSY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 27-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000150245. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.0 REMARK 210 IONIC STRENGTH : 0.076 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5-1.0 MM [U-13C; U-15N] CSK REMARK 210 SH2 DOMAIN-1, 20 MM SODIUM REMARK 210 PHOSPHATE-2, 50 MM SODIUM REMARK 210 CHLORIDE-3, 0.5-1.0 MM CBP REMARK 210 PHOSPHOPEPTIDE-4, 90 % H2O-5, 10 REMARK 210 % [U-99% 2H] D2O-6, 90% H2O/10% REMARK 210 D2O; 0.5-1.0 MM [U-15N] CSK SH2 REMARK 210 DOMAIN-7, 20 MM SODIUM PHOSPHATE- REMARK 210 8, 50 MM SODIUM CHLORIDE-9, 0.5- REMARK 210 1.0 MM CBP PHOSPHOPEPTIDE-10, 90 REMARK 210 % H2O-11, 10 % [U-99% 2H] D2O-12, REMARK 210 90% H2O/10% D2O; 0.5-1.0 MM [U- REMARK 210 13C; U-15N] CBP PHOSPHOPEPTIDE- REMARK 210 13, 20 MM SODIUM PHOSPHATE-14, REMARK 210 50 MM SODIUM CHLORIDE-15, 0.5- REMARK 210 1.0 MM CSK SH2 DOMAIN-16, 90 % REMARK 210 H2O-17, 10 % [U-99% 2H] D2O-18, REMARK 210 90% H2O/10% D2O; 0.5-1.0 MM [U- REMARK 210 15N] CBP PHOSPHOPEPTIDE-19, 20 REMARK 210 MM SODIUM PHOSPHATE-20, 50 MM REMARK 210 SODIUM CHLORIDE-21, 0.5-1.0 MM REMARK 210 CSK SH2 DOMAIN-22, 90 % H2O-23, REMARK 210 10 % [U-99% 2H] D2O-24, 90% H2O/ REMARK 210 10% D2O; 0.5-1.0 MM [U-13C; U- REMARK 210 15N] CSK SH2 DOMAIN-25, 20 MM REMARK 210 SODIUM PHOSPHATE-26, 50 MM REMARK 210 SODIUM CHLORIDE-27, 0.5-1.0 MM REMARK 210 CBP PHOSPHOPEPTIDE-28, 90 % H2O- REMARK 210 29, 10 % [U-99% 2H] D2O-30, 100% REMARK 210 D2O; 0.5-1.0 MM [U-13C; U-15N] REMARK 210 CBP PHOSPHOPEPTIDE-31, 20 MM REMARK 210 SODIUM PHOSPHATE-32, 50 MM REMARK 210 SODIUM CHLORIDE-33, 0.5-1.0 MM REMARK 210 CSK SH2 DOMAIN-34, 90 % H2O-35, REMARK 210 10 % [U-2H] D2O-36, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D HNCO; 3D HN(CA)CO; REMARK 210 3D HBHA(CO)NH; 3D 1H-15N TOCSY; REMARK 210 2D 1H-13C HSQC; 2D 1H-13C HSQC REMARK 210 AROMATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 2D DQF-COSY; 3D C(CO) REMARK 210 NH; 3D H(CCO)NH; 3D HCCH-TOCSY; REMARK 210 3D 1H-15N NOESY; 2D CBHD; 2D REMARK 210 CBHE; 3D 13C-FILTERED/13C-EDITED REMARK 210 NOESY; 3D 13C,15N-FILTERED/15N- REMARK 210 EDITED NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, SPARKY, TALOS, CYANA, REMARK 210 MOLMOL REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 77 39.73 -156.55 REMARK 500 1 SER A 79 64.50 -164.29 REMARK 500 1 LYS A 86 79.35 179.32 REMARK 500 1 LEU A 96 43.63 -101.89 REMARK 500 1 ILE A 168 -51.31 -127.24 REMARK 500 1 PHE B 291 131.94 -171.04 REMARK 500 1 SER B 293 -178.95 -59.42 REMARK 500 1 SER B 316 158.03 63.88 REMARK 500 2 SER A 79 60.38 -152.19 REMARK 500 2 LYS A 86 67.88 178.26 REMARK 500 2 LEU A 96 43.57 -100.27 REMARK 500 2 GLU A 143 -38.59 -132.43 REMARK 500 2 ILE A 168 -51.40 -127.05 REMARK 500 2 LYS A 171 84.90 -68.18 REMARK 500 2 PHE B 291 126.90 -175.45 REMARK 500 2 SER B 293 -172.72 -60.29 REMARK 500 2 LEU B 294 103.88 -163.84 REMARK 500 2 ASP B 302 78.16 -151.37 REMARK 500 2 SER B 316 150.63 65.06 REMARK 500 3 LYS A 86 65.79 178.79 REMARK 500 3 LEU A 96 43.48 -104.43 REMARK 500 3 GLU A 143 -38.70 -132.43 REMARK 500 3 ILE A 168 -51.22 -127.22 REMARK 500 3 PHE B 291 101.69 -171.81 REMARK 500 3 SER B 293 -172.02 -64.32 REMARK 500 3 LEU B 294 106.40 -162.95 REMARK 500 3 SER B 316 155.71 64.34 REMARK 500 4 LYS A 86 68.47 179.01 REMARK 500 4 LEU A 96 43.55 -102.32 REMARK 500 4 GLU A 143 -38.43 -132.29 REMARK 500 4 ILE A 168 -51.30 -126.94 REMARK 500 4 LYS A 171 83.78 -69.80 REMARK 500 4 ARG B 290 92.47 -179.90 REMARK 500 4 PHE B 291 108.96 179.18 REMARK 500 4 LEU B 294 98.46 -160.81 REMARK 500 4 ASP B 302 80.75 -156.39 REMARK 500 4 SER B 316 152.82 64.88 REMARK 500 5 SER A 79 27.65 -157.49 REMARK 500 5 MET A 80 72.68 -168.65 REMARK 500 5 LYS A 86 78.46 -179.96 REMARK 500 5 LEU A 96 43.12 -102.96 REMARK 500 5 ILE A 168 -51.11 -127.03 REMARK 500 5 LYS A 171 84.04 -69.66 REMARK 500 5 PHE B 291 83.24 -169.62 REMARK 500 5 SER B 292 99.88 -176.59 REMARK 500 5 LEU B 294 104.63 -163.81 REMARK 500 5 ASP B 302 79.92 -155.05 REMARK 500 5 SER B 316 153.66 64.74 REMARK 500 6 PRO A 76 -171.79 -69.73 REMARK 500 6 SER A 79 58.42 -170.28 REMARK 500 REMARK 500 THIS ENTRY HAS 203 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 11508 RELATED DB: BMRB DBREF 2RSY A 80 173 UNP P32577 CSK_RAT 80 173 DBREF 2RSY B 288 321 UNP Q9JM80 PHAG1_RAT 288 321 SEQADV 2RSY GLY A 75 UNP P32577 EXPRESSION TAG SEQADV 2RSY PRO A 76 UNP P32577 EXPRESSION TAG SEQADV 2RSY LEU A 77 UNP P32577 EXPRESSION TAG SEQADV 2RSY GLY A 78 UNP P32577 EXPRESSION TAG SEQADV 2RSY SER A 79 UNP P32577 EXPRESSION TAG SEQADV 2RSY GLY B 284 UNP Q9JM80 EXPRESSION TAG SEQADV 2RSY PRO B 285 UNP Q9JM80 EXPRESSION TAG SEQADV 2RSY LEU B 286 UNP Q9JM80 EXPRESSION TAG SEQADV 2RSY GLY B 287 UNP Q9JM80 EXPRESSION TAG SEQRES 1 A 99 GLY PRO LEU GLY SER MET PRO TRP PHE HIS GLY LYS ILE SEQRES 2 A 99 THR ARG GLU GLN ALA GLU ARG LEU LEU TYR PRO PRO GLU SEQRES 3 A 99 THR GLY LEU PHE LEU VAL ARG GLU SER THR ASN TYR PRO SEQRES 4 A 99 GLY ASP TYR THR LEU CYS VAL SER CYS GLU GLY LYS VAL SEQRES 5 A 99 GLU HIS TYR ARG ILE MET TYR HIS ALA SER LYS LEU SER SEQRES 6 A 99 ILE ASP GLU GLU VAL TYR PHE GLU ASN LEU MET GLN LEU SEQRES 7 A 99 VAL GLU HIS TYR THR THR ASP ALA ASP GLY LEU CYS THR SEQRES 8 A 99 ARG LEU ILE LYS PRO LYS VAL MET SEQRES 1 B 38 GLY PRO LEU GLY SER LYS ARG PHE SER SER LEU SER TYR SEQRES 2 B 38 LYS SER ARG GLU GLU ASP PRO THR LEU THR GLU GLU GLU SEQRES 3 B 38 ILE SER ALA MET PTR SER SER VAL ASN LYS PRO GLY MODRES 2RSY PTR B 314 TYR O-PHOSPHOTYROSINE HET PTR B 314 24 HETNAM PTR O-PHOSPHOTYROSINE HETSYN PTR PHOSPHONOTYROSINE FORMUL 2 PTR C9 H12 N O6 P HELIX 1 1 THR A 88 LEU A 96 1 9 HELIX 2 2 ASN A 148 ASP A 159 1 12 HELIX 3 3 THR B 306 MET B 313 1 8 SHEET 1 A 5 LYS A 137 SER A 139 0 SHEET 2 A 5 LYS A 125 HIS A 134 -1 N HIS A 134 O LYS A 137 SHEET 3 A 5 TYR A 116 CYS A 122 -1 N TYR A 116 O ILE A 131 SHEET 4 A 5 LEU A 103 GLU A 108 -1 N LEU A 105 O CYS A 119 SHEET 5 A 5 LYS A 169 PRO A 170 1 O LYS A 169 N PHE A 104 SSBOND 1 CYS A 122 CYS A 164 1555 1555 2.10 LINK C MET B 313 N PTR B 314 1555 1555 1.33 LINK C PTR B 314 N SER B 315 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000